{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-111391","form_type":"8-K","ticker":"GANX","cik":"0001819411","company_name":"Gain Therapeutics, Inc.","filed_at":"2026-09-28T20:30:45+00:00","discovered_at":"2026-09-28T20:32:44.853874+00:00","generated_at":"2026-10-12T13:36:43.882042+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Gain Therapeutics CFO Gianluca Fuggetta resigns Sept 30; CEO Gene Mack named interim CFO","bullets":["Gianluca Fuggetta, SVP of Finance and principal financial and accounting officer, notified the company on Sept 22, 2026 of his resignation effective Sept 30, 2026 to pursue other opportunities.","Board appointed President and CEO Gene Mack as interim CFO effective Oct 1, 2026; he will also assume principal financial officer and principal accounting officer duties.","Mack continues as President and CEO; the company said it is engaged in an ongoing search for a permanent replacement for the principal financial/accounting officer roles.","Mack's compensatory and other material employment terms remain unchanged in connection with the interim CFO appointment.","No arrangements or understandings between Mack and any other persons led to his selection, and no Item 404(a) related-party transactions were disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-111391","json":"https://secwatch.observer/filing/0001104659-26-111391.json","markdown":"https://secwatch.observer/filing/0001104659-26-111391.md","text":"https://secwatch.observer/filing/0001104659-26-111391.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819411/000110465926111391/0001104659-26-111391-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819411/000110465926111391/tm2626106d1_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T13:36:43.882042+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}